These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32247821)

  • 21. Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera.
    Jairajpuri MA; Ansari S
    Clin Sci (Lond); 2020 Sep; 134(17):2235-2241. PubMed ID: 32869854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical screening for SARS-CoV-2 main protease inhibitors.
    Coelho C; Gallo G; Campos CB; Hardy L; Würtele M
    PLoS One; 2020; 15(10):e0240079. PubMed ID: 33022015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
    Li Z; Li X; Huang YY; Wu Y; Liu R; Zhou L; Lin Y; Wu D; Zhang L; Liu H; Xu X; Yu K; Zhang Y; Cui J; Zhan CG; Wang X; Luo HB
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27381-27387. PubMed ID: 33051297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
    Gentile D; Patamia V; Scala A; Sciortino MT; Piperno A; Rescifina A
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32340389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.
    Hall DC; Ji HF
    Travel Med Infect Dis; 2020; 35():101646. PubMed ID: 32294562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease.
    Fu L; Ye F; Feng Y; Yu F; Wang Q; Wu Y; Zhao C; Sun H; Huang B; Niu P; Song H; Shi Y; Li X; Tan W; Qi J; Gao GF
    Nat Commun; 2020 Sep; 11(1):4417. PubMed ID: 32887884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking.
    Joshi T; Joshi T; Sharma P; Mathpal S; Pundir H; Bhatt V; Chandra S
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4529-4536. PubMed ID: 32373991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
    Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA
    Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
    Dai W; Zhang B; Jiang XM; Su H; Li J; Zhao Y; Xie X; Jin Z; Peng J; Liu F; Li C; Li Y; Bai F; Wang H; Cheng X; Cen X; Hu S; Yang X; Wang J; Liu X; Xiao G; Jiang H; Rao Z; Zhang LK; Xu Y; Yang H; Liu H
    Science; 2020 Jun; 368(6497):1331-1335. PubMed ID: 32321856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL
    Chitranshi N; Gupta VK; Rajput R; Godinez A; Pushpitha K; Shen T; Mirzaei M; You Y; Basavarajappa D; Gupta V; Graham SL
    J Transl Med; 2020 Jul; 18(1):278. PubMed ID: 32646487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor.
    Feitosa EL; Júnior FTDSS; Nery Neto JAO; Matos LFL; Moura MHS; Rosales TO; De Freitas GBL
    Int J Med Sci; 2020; 17(14):2133-2146. PubMed ID: 32922174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of M
    Jin Z; Du X; Xu Y; Deng Y; Liu M; Zhao Y; Zhang B; Li X; Zhang L; Peng C; Duan Y; Yu J; Wang L; Yang K; Liu F; Jiang R; Yang X; You T; Liu X; Yang X; Bai F; Liu H; Liu X; Guddat LW; Xu W; Xiao G; Qin C; Shi Z; Jiang H; Rao Z; Yang H
    Nature; 2020 Jun; 582(7811):289-293. PubMed ID: 32272481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
    Jin Z; Zhao Y; Sun Y; Zhang B; Wang H; Wu Y; Zhu Y; Zhu C; Hu T; Du X; Duan Y; Yu J; Yang X; Yang X; Yang K; Liu X; Guddat LW; Xiao G; Zhang L; Yang H; Rao Z
    Nat Struct Mol Biol; 2020 Jun; 27(6):529-532. PubMed ID: 32382072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL
    Chen YW; Yiu CB; Wong KY
    F1000Res; 2020; 9():129. PubMed ID: 32194944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and Computational Approach of Selected Phytocompounds from
    Rakib A; Paul A; Chy MNU; Sami SA; Baral SK; Majumder M; Tareq AM; Amin MN; Shahriar A; Uddin MZ; Dutta M; Tallei TE; Emran TB; Simal-Gandara J
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry.
    Gurard-Levin ZA; Liu C; Jekle A; Jaisinghani R; Ren S; Vandyck K; Jochmans D; Leyssen P; Neyts J; Blatt LM; Beigelman L; Symons JA; Raboisson P; Scholle MD; Deval J
    Antiviral Res; 2020 Oct; 182():104924. PubMed ID: 32896566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov.
    Zhang H; Saravanan KM; Yang Y; Hossain MT; Li J; Ren X; Pan Y; Wei Y
    Interdiscip Sci; 2020 Sep; 12(3):368-376. PubMed ID: 32488835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation.
    Keretsu S; Bhujbal SP; Cho SJ
    Sci Rep; 2020 Oct; 10(1):17716. PubMed ID: 33077821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repositioning of 8565 Existing Drugs for COVID-19.
    Gao K; Nguyen DD; Chen J; Wang R; Wei GW
    J Phys Chem Lett; 2020 Jul; 11(13):5373-5382. PubMed ID: 32543196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(697):1218-1219. PubMed ID: 32520464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.